STKLD1

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

• Limb disorders

  Unknown

Disease associations (Open Targets)

• breast cancer

  0.18

• COVID-19

  0.18

• Splenomegaly

  0.11

• asthma

  0.10

• metabolic syndrome

  0.07

• myocardial infarction

  0.02

• progressive pseudorheumatoid arthropathy of childhood

  0.00

• acute myeloid leukemia

  0.00

• lymphoma

  0.00

• gastric cancer

  0.00

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.